Your session is about to expire
← Back to Search
Cooling Device
Non-shivering cooling group for Fever
N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 minutes
Awards & highlights
Study Summary
This trial compared three different devices for cooling patients who can't shiver. This is important for protocols to cool patients with heart attacks or strokes.
Eligible Conditions
- Fever
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 120 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Esophageal temperature cooling rate
Skin heat exchange
Trial Design
1Treatment groups
Experimental Treatment
Group I: Non-shivering cooling groupExperimental Treatment3 Interventions
Cooling devices
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Arctic Sun
2020
N/A
~20
Blanketrol and Kool Kit
2020
N/A
~20
Blanketrol cooling device and water-perfused blankets
2020
N/A
~20
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,510 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger